Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Brisbane, California
- Most recent report
- 8-K, filed Oct 8, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1396814
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 50
News 8 of 164
Prospectuses and Registrations 8 of 14
- S-8 Registration statement for an employee plan Aug 4, 2026
- S-8 Registration statement for an employee plan Feb 26, 2026
- S-8 Registration statement for an employee plan Aug 5, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
- S-8 Registration statement for an employee plan Feb 29, 2024
- S-8 Registration statement for an employee plan Aug 2, 2023
- S-8 Registration statement for an employee plan Aug 4, 2022
- S-8 Registration statement for an employee plan Aug 3, 2021
Proxies 8 of 34
- DEFA14A Extra proxy material Jun 4, 2026
- DEFA14A Extra proxy material Jun 1, 2026
- DEFA14A Extra proxy material May 28, 2026
- DEFA14A Extra proxy material May 27, 2026
- DEFA14A Extra proxy material May 26, 2026
- DEFA14A Extra proxy material May 20, 2026
- DEFA14A Extra proxy material May 20, 2026
- DEFA14A Extra proxy material May 13, 2026
Ownership 8 of 687
- SCHEDULE 13D/A Large holder reported an active stake, amended Oct 13, 2026
- 4 Insider reported a trade Oct 9, 2026
- 144 Notice of a proposed sale of restricted stock Oct 8, 2026
- 4 Insider reported a trade Aug 18, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
Other 8 of 51
Everything here comes from Pacira BioSciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.